Defining and characterizing sustained remission in patients with rheumatoid arthritis
Crossref DOI link: https://doi.org/10.1007/s10067-017-3923-z
Published Online: 2017-12-09
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Curtis, Jeffrey R.
Trivedi, Mona
Haraoui, Boulos
Emery, Paul
Park, Grace S.
Collier, David H.
Aras, Girish A.
Chung, James
Funding for this research was provided by:
Immunex, a wholly owned subsidiary of Amgen Inc.
License valid from 2017-12-09